These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Medicaid and indigent care issue brief: Medicaid: provider reimbursement: year end report-2003. Johnson P Issue Brief Health Policy Track Serv; 2003 Dec; ():1-25. PubMed ID: 14969256 [TBL] [Abstract][Full Text] [Related]
5. Controlling pharmacy costs in the NC Medicaid program. Dobson LA N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617 [No Abstract] [Full Text] [Related]
6. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services. LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393 [TBL] [Abstract][Full Text] [Related]
7. The tripartite reimbursement incentive model: a new method to eliminate the discounting of the copayment charge. Paul SH Med Mark Media; 1981 Mar; 16(3):35-9. PubMed ID: 10298125 [No Abstract] [Full Text] [Related]
9. Fresh Approaches to Addressing High Drug Costs. Armstrong J; Becker C NCSL Legisbrief; 2019 Apr; 27(15):1-2. PubMed ID: 30990598 [No Abstract] [Full Text] [Related]
10. Managing Medicaid drug expenditures. Sudovar SG; Rein SD J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767 [No Abstract] [Full Text] [Related]
11. Potential impact of prepayment on Medicaid drug costs. Yesalls CE; Norwood GJ; Lipson DP Contemp Pharm Pract; 1979; 2(2):87-94. PubMed ID: 10297462 [No Abstract] [Full Text] [Related]
12. Reimbursement for nondispensing functions: today's innovation is tomorrow's tradition. Miller JW Contemp Pharm Pract; 1979; 2(2):95-8. PubMed ID: 10297463 [No Abstract] [Full Text] [Related]
13. Medicaid and indigent care issue brief: Medicaid: provider reimbursement. Johnson P Issue Brief Health Policy Track Serv; 2000 Jul; ():1-15. PubMed ID: 11073441 [TBL] [Abstract][Full Text] [Related]
14. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations. Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564 [No Abstract] [Full Text] [Related]
15. Payment reform at one year: much accomplished, much left to do. Allison A J Ark Med Soc; 2013 Aug; 110(2):38-40. PubMed ID: 24015446 [No Abstract] [Full Text] [Related]
16. Medicaid and indigent care issue brief: Medicaid: provider reimbursement: year end report-2004. Johnson P Issue Brief Health Policy Track Serv; 2004 Dec; ():1-24. PubMed ID: 15747439 [No Abstract] [Full Text] [Related]
17. Payers need to streamline Part D turnaround time to head off potential regulatory changes. Med Health; 2006 Apr; 60(15):1-2. PubMed ID: 16623183 [No Abstract] [Full Text] [Related]
18. Medicaid pharmacy program becoming model for improved care, reduced costs. Public Sect Contract Rep; 1997 Jun; 3(6):86-9. PubMed ID: 10175082 [No Abstract] [Full Text] [Related]
19. Medicaid reimbursement for alternative therapies. Steyer TE; Freed GL; Lantz PM Altern Ther Health Med; 2002; 8(6):84-8. PubMed ID: 12440844 [TBL] [Abstract][Full Text] [Related]
20. Insurance reimbursement policies and AIDS home healthcare: public and private financing mechanisms. Hanley BE AIDS Public Policy J; 1996; 11(2):89-103. PubMed ID: 10915242 [No Abstract] [Full Text] [Related] [Next] [New Search]